R Nisha Aurora1, Ciprian Crainiceanu2, Daniel J Gottlieb3,4, Ji Soo Kim2, Naresh M Punjabi1,5. 1. 1 Department of Medicine. 2. 2 Department of Biostatistics, and. 3. 3 Veterans Affairs Boston Healthcare System, Boston, Massachusetts; and. 4. 4 Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 5. 5 Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland.
Abstract
RATIONALE: Obstructive sleep apnea (OSA) during REM sleep is a common disorder. Data on whether OSA that occurs predominantly during REM sleep is associated with health outcomes are limited. OBJECTIVES: The present study examined the association between OSA during REM sleep and a composite cardiovascular endpoint in a community sample with and without prevalent cardiovascular disease. METHODS: Full-montage home polysomnography was conducted as part of the Sleep Heart Health Study. The study cohort was followed for an average of 9.5 years, during which time cardiovascular events were assessed. Only participants with a non-REM apnea-hypopnea index (AHI) of less than 5 events/h were included. A composite cardiovascular endpoint was determined as the occurrence of nonfatal or fatal events, including myocardial infarction, coronary artery revascularization, congestive heart failure, and stroke. Proportional hazards regression was used to derive the adjusted hazards ratios for the composite cardiovascular endpoint. MEASUREMENTS AND MAIN RESULTS: The sample consisted of 3,265 subjects with a non-REM AHI of less than 5.0 events/h. Using a REM AHI of less than 5.0 events/h as the reference group (n = 1,758), the adjusted hazards ratios for the composite cardiovascular endpoint in those with severe REM OSA (≥30 events/h; n = 180) was 1.35 (95% confidence interval, 0.98-1.85). Stratified analyses demonstrated that the association was most notable in those with prevalent cardiovascular disease and severe OSA during REM sleep with an adjusted hazards ratio of 2.56 (95% confidence interval, 1.46-4.47). CONCLUSIONS: Severe OSA that occurs primarily during REM sleep is associated with higher incidence of a composite cardiovascular endpoint, but in only those with prevalent cardiovascular disease.
RATIONALE: Obstructive sleep apnea (OSA) during REM sleep is a common disorder. Data on whether OSA that occurs predominantly during REM sleep is associated with health outcomes are limited. OBJECTIVES: The present study examined the association between OSA during REM sleep and a composite cardiovascular endpoint in a community sample with and without prevalent cardiovascular disease. METHODS: Full-montage home polysomnography was conducted as part of the Sleep Heart Health Study. The study cohort was followed for an average of 9.5 years, during which time cardiovascular events were assessed. Only participants with a non-REM apnea-hypopnea index (AHI) of less than 5 events/h were included. A composite cardiovascular endpoint was determined as the occurrence of nonfatal or fatal events, including myocardial infarction, coronary artery revascularization, congestive heart failure, and stroke. Proportional hazards regression was used to derive the adjusted hazards ratios for the composite cardiovascular endpoint. MEASUREMENTS AND MAIN RESULTS: The sample consisted of 3,265 subjects with a non-REM AHI of less than 5.0 events/h. Using a REM AHI of less than 5.0 events/h as the reference group (n = 1,758), the adjusted hazards ratios for the composite cardiovascular endpoint in those with severe REM OSA (≥30 events/h; n = 180) was 1.35 (95% confidence interval, 0.98-1.85). Stratified analyses demonstrated that the association was most notable in those with prevalent cardiovascular disease and severe OSA during REM sleep with an adjusted hazards ratio of 2.56 (95% confidence interval, 1.46-4.47). CONCLUSIONS: Severe OSA that occurs primarily during REM sleep is associated with higher incidence of a composite cardiovascular endpoint, but in only those with prevalent cardiovascular disease.
Authors: Jayne C Carberry; Hanna Hensen; Lauren P Fisher; Julian P Saboisky; Jane E Butler; Simon C Gandevia; Danny J Eckert Journal: J Appl Physiol (1985) Date: 2015-03-06
Authors: Babak Mokhlesi; Laurel A Finn; Erika W Hagen; Terry Young; Khin Mae Hla; Eve Van Cauter; Paul E Peppard Journal: Am J Respir Crit Care Med Date: 2014-11-15 Impact factor: 21.405
Authors: Shahrokh Javaheri; Ferran Barbe; Francisco Campos-Rodriguez; Jerome A Dempsey; Rami Khayat; Sogol Javaheri; Atul Malhotra; Miguel A Martinez-Garcia; Reena Mehra; Allan I Pack; Vsevolod Y Polotsky; Susan Redline; Virend K Somers Journal: J Am Coll Cardiol Date: 2017-02-21 Impact factor: 24.094
Authors: Chi-Hang Lee; See-Meng Khoo; Mark Y Chan; Hwee-Bee Wong; Adrian F Low; Qian-Hui Phua; A Mark Richards; Huay-Cheem Tan; Tiong-Cheng Yeo Journal: J Clin Sleep Med Date: 2011-12-15 Impact factor: 4.062
Authors: Jan Polak; Larissa A Shimoda; Luciano F Drager; Clark Undem; Holly McHugh; Vsevolod Y Polotsky; Naresh M Punjabi Journal: Sleep Date: 2013-10-01 Impact factor: 5.849
Authors: Diego R Mazzotti; Brendan T Keenan; Diane C Lim; Daniel J Gottlieb; Jinyoung Kim; Allan I Pack Journal: Am J Respir Crit Care Med Date: 2019-08-15 Impact factor: 21.405
Authors: Tetyana Kendzerska; Richard S Leung; Clare L Atzema; George Chandy; Moussa Meteb; Atul Malhotra; Gillian A Hawker; Andrea S Gershon Journal: Sleep Med Date: 2019-09-11 Impact factor: 3.492